Literature DB >> 25381753

Diagnostic accuracy of behavioral variant frontotemporal dementia consortium criteria (FTDC) in a clinicopathological cohort.

Mircea Balasa1, Ellen Gelpi2, Idaira Martín1, Anna Antonell1, Ma Jesus Rey2, Oriol Grau-Rivera1,2, José Luis Molinuevo1, Raquel Sánchez-Valle1, Albert Lladó1.   

Abstract

AIMS: The aims of this study were to assess the sensitivity of the International Behavioural Variant FTD Criteria Consortium (FTDC) revised criteria of behavioural variant frontotemporal dementia (bvFTD) in a pathological cohort and to determine their predictive values in a clinical context suggestive of bvFTD. In addition, the study aimed to assess the influence of the age at onset and underlying pathology in the clinicopathological correlations.
METHODS: Retrospective, blinded review of the clinical and neuropathological data from the Neurological Tissue Bank of the Biobank Hospital Clinic-IDIBAPS, Barcelona (Spain) was conducted, assessing the fulfilment of the diagnostic criteria on a case-by-case basis. Two separate nonexclusive cohorts were selected: Cohort 1 (n = 58) subjects with pathological diagnosis of frontotemporal lobar degeneration (FTLD) and Cohort 2 (n = 66) subjects with the premortem diagnosis of bvFTD.
RESULTS: The FTDC criteria reached a sensitivity of 93% for possible and 80% for probable bvFTD. Early-onset cases displayed significantly more disinhibition, loss of empathy and compulsive behaviour with respect to late-onset bvFTD, leading to a slightly higher sensitivity of the diagnostic criteria (97% vs. 91%). There were no differences in the diagnostic performance between tau-positive and tau-negative cases. In subjects clinically diagnosed as bvFTD, a 'possible bvFTD' diagnosis reached a positive predictive value for FTLD pathology of 90%, irrespective of underlying proteinopathy. False-positive clinical diagnoses were mainly Alzheimer's disease. These cases were significantly older, had less family history of dementia and had a predominantly apathetic clinical picture.
CONCLUSIONS: The revised bvFTD criteria present good sensitivity and positive predictive value in both early- and late-onset cases and regardless of the underlying FTLD pathology.
© 2014 British Neuropathological Society.

Entities:  

Keywords:  behavioural variant; diagnostic criteria; frontotemporal dementia

Mesh:

Year:  2015        PMID: 25381753     DOI: 10.1111/nan.12194

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  7 in total

Review 1.  Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia.

Authors:  Nasim Sheikh-Bahaei; Seyed Ahmad Sajjadi; Aimee L Pierce
Journal:  Curr Treat Options Neurol       Date:  2017-11-14       Impact factor: 3.598

2.  Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy.

Authors:  Ignacio Illán-Gala; Victor Montal; Sergi Borrego-Écija; Eduard Vilaplana; Jordi Pegueroles; Daniel Alcolea; Belén Sánchez-Saudinós; Jordi Clarimón; Janina Turón-Sans; Nuria Bargalló; Sofía González-Ortiz; Howard J Rosen; Maria Luisa Gorno-Tempini; Bruce L Miller; Albert Lladó; Ricard Rojas-García; Rafael Blesa; Raquel Sánchez-Valle; Alberto Lleó; Juan Fortea
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

Review 3.  Convergent regional brain abnormalities in behavioral variant frontotemporal dementia: A neuroimaging meta-analysis of 73 studies.

Authors:  Aida Kamalian; Tina Khodadadifar; Amin Saberi; Maryam Masoudi; Julia A Camilleri; Claudia R Eickhoff; Mojtaba Zarei; Lorenzo Pasquini; Angela R Laird; Peter T Fox; Simon B Eickhoff; Masoud Tahmasian
Journal:  Alzheimers Dement (Amst)       Date:  2022-05-29

4.  Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases.

Authors:  Geidy E Serrano; Anthony Intorcia; Jeremiah Carew; Glenn Chiarolanza; Jose A Hidalgo; Lucia I Sue; Brittany N Dugger; Megan Saxon-LaBelle; Jessica Filon; Alex Scroggins; Joel Pullen; Brandon E Fornwalt; Sarah Scott; Marwan N Sabbagh; Charles H Adler; Haruhiko Akiyama; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

5.  The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical Implications.

Authors:  Helena Gossye; Christine Van Broeckhoven; Sebastiaan Engelborghs
Journal:  Front Neurosci       Date:  2019-08-06       Impact factor: 4.677

6.  Diagnostic Utility of Measuring Cerebral Atrophy in the Behavioral Variant of Frontotemporal Dementia and Association With Clinical Deterioration.

Authors:  Ignacio Illán-Gala; Neus Falgàs; Adit Friedberg; Sheila Castro-Suárez; Ophir Keret; Nicole Rogers; Didem Oz; Salvatore Nigro; Andrea Quattrone; Aldo Quattrone; Amy Wolf; Kyan Younes; Miguel Santos-Santos; Sergi Borrego-Écija; Yann Cobigo; Oriol Dols-Icardo; Albert Lladó; Raquel Sánchez-Valle; Jordi Clarimon; Rafael Blesa; Daniel Alcolea; Juan Fortea; Alberto Lleó; Lea T Grinberg; Salvatore Spina; Joel H Kramer; Gil D Rabinovici; Adam Boxer; Maria Luisa Gorno Tempini; Bruce L Miller; William W Seeley; Howard J Rosen; David C Perry
Journal:  JAMA Netw Open       Date:  2021-03-01

7.  Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia Diagnosis.

Authors:  Antti Cajanus; Anette Hall; Juha Koikkalainen; Eino Solje; Antti Tolonen; Timo Urhemaa; Yawu Liu; Ramona M Haanpää; Päivi Hartikainen; Seppo Helisalmi; Ville Korhonen; Daniel Rueckert; Steen Hasselbalch; Gunhild Waldemar; Patrizia Mecocci; Ritva Vanninen; Mark van Gils; Hilkka Soininen; Jyrki Lötjönen; Anne M Remes
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2018-02-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.